FFA
DNA icon

Farther Finance Advisors’s Ginkgo Bioworks DNA Stock Holding History

Farther Finance Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.27K Sell
489
-119
-20% -$970 ﹤0.01% 4878
2026
Q2 		$6.05K Buy
608
+276
+83% +$2.31K ﹤0.01% 4695
2026
Q1 		$2.25K Sell
332
-507
-60% -$4.22K ﹤0.01% 4856
2025
Q4 		$6.97K Buy
839
+125
+18% +$1.35K ﹤0.01% 4143
2025
Q3 		$10.4K Buy
714
+649
+998% +$7.77K ﹤0.01% 3427
2025
Q2 		$731 Sell
65
-37
-36% -$287 ﹤0.01% 3964
2025
Q1 		$577 Buy
102
+37
+57% +$377 ﹤0.01% 3750
2024
Q4 		$638 Buy
65
+50
+333% +$429 ﹤0.01% 3386
2024
Q3 		$122 Sell
15
-1
-6% -$10 ﹤0.01% 3742
2024
Q2 		$207 Hold
16
– – ﹤0.01% 3488
2024
Q1 		$716 Sell
16
-44
-73% -$2.28K ﹤0.01% 2901
2023
Q4 		$4.06K Buy
+60
New +$3.67K ﹤0.01% 2078
2023
Q1 		– Sell
-7
Closed -$477 – 2370
2022
Q4 		$477 Buy
+7
New +$644 ﹤0.01% 1836

Other funds holding DNA

QFMHK
Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return
BSWM
Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return
TWM
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Farther Finance Advisors's DNA Position: Q3 2026 in Review

Farther Finance Advisors reduced its Ginkgo Bioworks (DNA) stake by 20% in Q3 2026, selling an estimated $970 and leaving 489 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #4878.

Farther Finance Advisors first reported a position in DNA in Q4 2022 and has held it in 13 quarters since. The position peaked at $10.4K in Q3 2025. 10 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Farther Finance Advisors held 489 shares of Ginkgo Bioworks worth $6.27K as of Q3 2026.
  • Farther Finance Advisors sold 119 Ginkgo Bioworks shares in Q3 2026, an estimated $970.
  • Ginkgo Bioworks made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4878 holding.
  • Farther Finance Advisors first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 13 quarters since.
  • Farther Finance Advisors's Ginkgo Bioworks position peaked at $10.4K in Q3 2025.
  • 10 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.